SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-159340
Filing Date
2018-05-10
Accepted
2018-05-10 17:02:00
Documents
72
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d539562d10q.htm 10-Q 431078
2 EX-31.1 d539562dex311.htm EX-31.1 6315
3 EX-31.2 d539562dex312.htm EX-31.2 6377
4 EX-32.1 d539562dex321.htm EX-32.1 2825
5 EX-32.2 d539562dex322.htm EX-32.2 2930
  Complete submission text file 0001193125-18-159340.txt   3500624

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bdsi-20180331.xml EX-101.INS 544572
7 XBRL TAXONOMY EXTENSION SCHEMA bdsi-20180331.xsd EX-101.SCH 51350
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bdsi-20180331_cal.xml EX-101.CAL 68170
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bdsi-20180331_def.xml EX-101.DEF 174750
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdsi-20180331_lab.xml EX-101.LAB 390538
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdsi-20180331_pre.xml EX-101.PRE 295311
Mailing Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612
Business Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Filer) CIK: 0001103021 (see all company filings)

IRS No.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31361 | Film No.: 18823841
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences